Akèy › Kansè bouch › North Dakota › Bismarck
Etid klinik pou Kansè bouch nan Bismarck, ND
3 etid pou Kansè bouch ap chèche patisipan nan sit nan ak bò kote Bismarck (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Ap rekriteFaz 3
- Sanford Bismarck Medical Center, Bismarck
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Ap rekriteFaz 2
- Sanford Bismarck Medical Center, Bismarck
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Ap rekriteFaz 2
- Sanford Bismarck Medical Center, Bismarck
Etid Kansè bouch nan lòt vil
- Atlanta, GA9 etid
- St. Louis, MO8 etid
- New York City, NY8 etid
- Chicago, IL8 etid
- Durham, NC7 etid
- Houston, TX7 etid
- Kansas City, MO7 etid
- Milwaukee, WI7 etid
- Portland, OR7 etid
- Ann Arbor, MI7 etid
- Pittsburgh, PA7 etid
- Richmond, VA7 etid
Lòt etid nan Bismarck
- Kansè poumon9 etid
- Kansè Poumon ki pa ti selil6 etid
- Karsinòm selil skuamèz tèt ak kou5 etid
- Kansè nan tete3 etid
- Kansè pankreyas3 etid
- Kansè rektal3 etid
- Kansè kolon3 etid
- Kansè pwostat3 etid
- Kansè Ipofaringe3 etid
- Kansè larinks3 etid
- Kansè kolorektal3 etid
- Melanom3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.